Pfizer | Business Post

Pfizer questioned government over release of records to Business Post under FOI

Pharma giant asked the government for meeting to discussion Freedom of Information ahead of meeting last June

Pfizer to cut 100 jobs at Irish plant – but signals 230 new jobs in other locations

Pharma giant is laying off staff who work on manufacturing Covid drug, with impacted staff told they may be redeployed to other locations

Pfizer staff expect word on Irish layoffs by end of month

Pharma firm intends cuts of $3.5 billion by the end of 2024 after $12 billion drop in revenue due to Covid ‘fatigue’

Dairy farmers urge State to do ‘everything in its power’ to keep Askeaton plant open

Irish Creamery Milk Suppliers Association described Nestlé’s infant formula plant in Limerick as ‘huge economic asset’ that must be protected

Pfizer weighs up Irish job cuts as part of a planned $3.5bn cost-cutting programme

The US pharma giant said demand for Covid-19 vaccines and other key drugs made in Ireland had fallen sharply this year

Pfizer warns state new EU pharma plans will damage Ireland’s competitiveness

Pharma giant wants Irish government to oppose new plans that aim to make access to medicines more secure and affordable

FDI up 15 per cent last year, led by pharma and IT sectors

Pfizer facility in Dublin and Eli Lilly factory in Limerick account for €2.4 billion, while Intel plans to invest €12 billion to expand operations here

Three multinationals accounted for one third of all corporate tax receipts from 2017-2021

Research paper from the Irish Fiscal Advisory council estimates that just three large companies paid over €5.2bn in corporate tax to the state in 2021

Hundreds of plumbers to strike at Intel and Pfizer sites despite employer’s bid for injunction

Jones Engineering had tried to get High Court action to stop industrial action, but strikes are to proceed in a dispute over travel allowance for plumbers

World’s biggest pet health firm Zoetis to invest €150m in Offaly plant expansion

Animal health spinout from Pfizer to spend €300m on pet vaccine factory, which will provide 100 jobs

Pfizer warned government that low drug budget will delay access to new medicines

The pharma giant, which employs around 4,000 people here, said Ireland was 24th out of 35 countries for the availability of new medicines

Cost of AstraZeneca’s next-gen Dublin project may top €600m

Manufacturing facility likely to be much larger than initially planned

Pfizer chief: €1.2 billion Irish investment is just the start

Mike McDermott, chief global supply officer and executive vice-president, says Pfizer will continue to invest in its Irish operations beyond the major Grange Castle investment announced last week

Carrick Therapeutics lands $35m investment from Pfizer

Dublin-based biopharma firm has received investment to support the rapid development of its flagship drug samuraciclib which is used in the treatment of HR+, HER2- breast cancer

Up to 500 jobs to be created at Pfizer’s new ‘state of the art’ Dublin plant

The company will invest €1.2 billion in the facility, which is expected to be completed by 2027

Eli Lilly’s investment in new biopharma plant will be at least €1.2 billion

Amount that US pharma giant is investing in Limerick facility is much more than originally thought, as scale and fit-out of campus emerges

Today's headlines

Pfizer to invest €1bn in new Dublin plant; Irish government hopes for Sunak as next UK PM

The top stories from business and politics in today’s Business Post

Exclusive: Pfizer to invest €1 billion in new Dublin biotech plant

The company, which already employs 4,000 people in Ireland, is understood to be at an advanced stage in its plans for the facility which would be one of the largest pharmaceutical investments in the history of the state

Pfizer warned government over changes to corporate tax

Pharmaceutical giant said elements of the plan to overhaul tax rules would create ‘winners and losers’

DPS €295m deal will be ‘game changer’ for engineering services sector

Dutch company Arcadis’s purchase of the Dublin-based firm will give it a new global reach, say industry sources